MedPath

Study of the effects of casein-derived peptides on cognitive function -A randomized, double-blind, placebo-controlled, parallel-group study

Not Applicable
Conditions
one
Registration Number
JPRN-UMIN000032833
Lead Sponsor
Matsumoto Junior College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who have been diagnosed with dementia or suspected of dementia. 2) Subjects who have been suspected of mental disorders such as schizophrenia and depression. 3) Subjects who have serious disease or medical history in brain, liver, kidney, heart, lung, gastrointestinal tract, blood, or endocrine metabolism, etc. 4) Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study. 5) Subjects who have a medical history of serious allergy to medicine and food. 6) Subjects who are judged unsuitable for participating in this study by doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
europsychological tests (ADAS-Jcog)
Secondary Outcome Measures
NameTimeMethod
europsychological tests (HDS-R, MoCA-J) QO
© Copyright 2025. All Rights Reserved by MedPath